Here, we extend the notion that C/EBPδ seems to exert opposing effects in tumor and non-tumor cells by showing that macrophage C/EBPδ limits the cytotoxicity of gemcitabine towards pancreatic cancer cells. Here, CEBPD is linked to familial pancreatic carcinoma.